Provided by the American Society for Clinical Pathology in partnership with Q Synthesis LLC.
This activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team prepare for the emerging era of “HER2-low” breast cancer. This activity outlines ways to prepare for changes in clinical practice that may be needed as targeted therapies for patients with HER2-low breast cancer begin to emerge.
Target Audience
This activity has been designed to meet the educational needs of pathologists, laboratory professionals, and other members of the cancer care team involved in diagnosing patients with breast cancer.
Activity Agenda
· Background
· Definition of “HER2-low”
· DESTINY-Breast04
· Anticipating Challenges and Opportunities
· Conclusion
Learning Objectives
Upon completion of this activity, you will be able to:
· Update laboratory processes and procedures around HER2 classification in breast cancer
· Outline ways to improve communication and coordination among pathologists, oncologists, and other members of the cancer care team when discussing HER2 test results in patients with breast cancer
Faculty
Joseph Kim, MD, MPH, MBA
President
Q Synthesis LLC
Langhorne, PA
Faculty Disclosures
Joseph Kim, MD, MPH, MBA: No relevant financial relationships with any commercial interests.
The activity offers 1.0 CME/CMLE credit.
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this internet activity for a maximum of 1.0 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time
Method of Participation
To complete the activity and receive credit, the participant must attend the program. CME certificates will be provided on-line.
Commercial Support
Funded by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.